The 6 analysts offering 12-month price forecasts for Revolution Medicines Inc have a median target of 37.00, with a high estimate of 38.00 and a low estimate of 31.00. The median estimate represents a +85.19% increase from the last price of 19.98.
The current consensus among 7 polled investment analysts is to Buy stock in Revolution Medicines Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.64
Reporting Date Mar 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.